These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9668299)

  • 1. IFN-gamma is required to induce experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; Orn A; van der Meide PH; Link H
    Ann N Y Acad Sci; 1998 May; 841():576-9. PubMed ID: 9668299
    [No Abstract]   [Full Text] [Related]  

  • 2. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respective role of thymus and muscle in autoimmune myasthenia gravis.
    Moulian N; Wakkach A; Guyon T; Poëa S; Aïssaoui A; Levasseur P; Cohen-Kaminsky S; Berrih-Aknin S
    Ann N Y Acad Sci; 1998 May; 841():397-406. PubMed ID: 9668265
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
    Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
    J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro production of antiacetylcholine receptor antibody and IgG by peripheral blood lymphocytes of patients with myasthenia gravis.
    Yoshikawa H; Satoh K; Iwasa K; Takamori M
    Ann N Y Acad Sci; 1998 May; 841():351-4. PubMed ID: 9668257
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization of bm12 mice with high doses of acetylcholine receptor overcomes their resistance to experimental autoimmune myasthenia gravis.
    Karachunski PI; Ostlie NS; Lei S; Okita DK; Lindstrom JM; Conti-Fine BM
    Ann N Y Acad Sci; 1998 May; 841():555-9. PubMed ID: 9668294
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice.
    Sitaraman S; Metzger DW; Belloto RJ; Infante AJ; Wall KA
    J Neuroimmunol; 2000 Jul; 107(1):73-82. PubMed ID: 10808053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
    Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB; Li H; He B; Bakheit M; Levi M; Wahren B; Berglöf A; Sandstedt K; Link H; Shi FD
    Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL-5 during primary and secondary immune response to acetylcholine receptor.
    Poussin MA; Goluszko E; Franco JU; Christadoss P
    J Neuroimmunol; 2002 Apr; 125(1-2):51-8. PubMed ID: 11960640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anti-idiotopic antibody on the course of experimental autoimmune myasthenia gravis.
    Agius MA; Yuen E
    Ann N Y Acad Sci; 1998 May; 841():584-6. PubMed ID: 9668301
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.
    Lindstrom J
    Annu Rev Immunol; 1985; 3():109-31. PubMed ID: 2998417
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of clinical disease to antibody titre, proliferative response and neurophysiology in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1983 Mar; 51(3):543-50. PubMed ID: 6851245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody production by blood lymphocytes in myasthenia gravis: reduction in disease of long duration.
    Kaufman RL; Oger J
    Neurology; 1988 May; 38(5):818-21. PubMed ID: 3362384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose BAFF receptor specific mAb-siRNA conjugate generates Fas-expressing B cells in lymph nodes and high-affinity serum autoantibody in a myasthenia mouse model.
    Ibtehaj N; Huda R
    Clin Immunol; 2017 Mar; 176():122-130. PubMed ID: 28099879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.